Form 4 Tracker
Daniel J. Lippis

CVP, TAVR · 11 filings · Latest: Jul 10, 2026

Edwards Lifesciences Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
EW
Daniel J. LippisCVP, TAVRJul 10, 2026
Sale
$91.70619$56.8K40,033.91
EW
Daniel J. LippisCVP, TAVRJul 10, 2026
Option Exercise
$72.68619$45.0K40,652.91
EW
Daniel J. LippisCVP, TAVRJun 30, 2026
Sale
$91.40619$56.6K40,410.91
EW
Daniel J. LippisCVP, TAVRJun 30, 2026
Option Exercise
$72.68619$45.0K41,029.91
EW
Daniel J. LippisCVP, TAVRMay 18, 2026
Sale
$81.14620$50.3K40,410.91
EW
Daniel J. LippisCVP, TAVRMay 18, 2026
Option Exercise
$72.68620$45.1K41,030.91
EW
Lippis Daniel J.May 18, 2026
Proposed Sale
$81.141,858$150.8K
EW
Daniel J. LippisCVP, TAVRMay 4, 2026
Sale
$83.981,019$85.6K33,681.91
EW
Daniel J. LippisCVP, TAVRMay 4, 2026
Option Exercise
$59.261,019$60.4K34,700.91
EW
Daniel J. LippisCVP, TAVRMay 1, 2026
Sale
$83.011,019$84.6K33,933.91
EW
Daniel J. LippisCVP, TAVRMay 1, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Lippis Daniel J.May 4, 2026
Proposed Sale
$83.981,019$85.6K
EW
Daniel J. LippisCVP, TAVRApr 6, 2026
Sale
$80.981,019$82.5K33,933.91
EW
Daniel J. LippisCVP, TAVRApr 6, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Daniel J. LippisCVP, TAVRMar 11, 2026
Sale
$85.381,019$87.0K33,933.91
EW
Daniel J. LippisCVP, TAVRMar 11, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Lippis Daniel J.Mar 11, 2026
Proposed Sale
$85.383,057$261.0K
EW
Lippis Daniel J.Nov 10, 2025
Proposed Sale
$82.553,058$252.4K
EW
Lippis Daniel J.Jul 28, 2025
Proposed Sale
$79.464,114$326.9K
EW
Lippis Daniel J.May 9, 2025
Proposed Sale
$74.42330$24.6K

Page 1 of 2

Next →